BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

PRAX upcoming catalysts

Praxis Precision Medicines: 3 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (3 Phase 3), 1 upcoming FDA decision event(s), and in the last 12 months 2 readout(s) and 0 FDA event(s). Subscribe to PRAX (.ics).

Upcoming FDA decision events

DateEventStatusCompanyDrugSource
2026-12-27PDUFA date (company-disclosed)pendingPraxis Precision Medicines, Inc. PRAXulixacaltamidePDUFA December 27, 2026 - Praxis Precision Medicines, Inc. (ulixacaltamide)

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-12 est.P3Praxis Precision Medicines PRAXNCT07010471 A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineDevelopmental and Epileptic Encephalopathy 1active not recruiting160
2026-12 est.P3Praxis Precision Medicines PRAXNCT07019922 A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and SafetyEpileptic Encephalopathy; SCN2A Encephalopathyrecruiting40
2027-01 est.P3Praxis Precision Medicines PRAXNCT07505004 Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal SeizuresFocal Epilepsyactive not recruiting300

FDA decision events, last 12 months

DateEventStatusCompanyDrugSource
No FDA decision events in this window.

Trial readouts, last 12 months

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-05-14P2/P3Praxis Precision Medicines PRAXNCT06999902 Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)Focal Seizurecompleted255
2026-04-01P1/P2Praxis Precision Medicines PRAXNCT05737784 A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic EncephalopathySCN2A-DEE; Epilepsyactive not recruiting60

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.